Dunlee unveiled its new oncology bundles in the U.S. for the first time at Radiological Society of North America’s 2022 annual conference.

November 28, 2022 — Dunlee unveiled its new oncology bundles in the U.S. for the first time at Radiological Society of North America’s 2022 annual conference. The bundles combine components that have been tested and verified to work together so clinicians can offer state-of-the-art onboard Cone Beam CT (CBCT) in facilities. As cancer cases rise globally, an estimated 60% of new patients will need some form of radiation therapy, but only 25% of those patients will receive treatment, either because the equipment is not available or because treatment is too costly. It is estimated that by 2030, if every patient who needs radiotherapy has access to it, almost one million more lives will be saved every year worldwide. Image guidance has been a major breakthrough in efforts to make radiation therapy more precise, because it enables physicians to take images immediately before treatment while the patient is in the treatment position. 

The oncology bundles include: 

  • X-ray Tubes, which customers rely on Dunlee products’ small focal spot size to enable high resolution imaging 
  • X-ray Flat Panel Detectors, providing excellent soft tissue visualization to identify tumor borders, a large field of view, fast frame speed of up to 150 frames-per-second, sharp images, and minimal motion artifacts 
  • Anti-scatter Grids, which significantly improve soft tissue visibility and uniformity without the need to increase imaging dose 
  • Cables, including all modifications customers need for efficient integration into their linear accelerator 

Dunlee offers two types of bundles, which combine successful and proven imaging solutions with the specific needs of image guidance in therapy: 

  • DA1094 X-ray Tube Bundle, which consists of a flat panel detector, DA 1094 X-ray tube, anti-scatter grid and high voltage cables 
  • Grid and Detector Bundle, which combines a state-of-the-art anti-scatter grid with the Dunlee XD-300 Detector for excellent soft tissue visualization and fast operation 
  • Dunlee Solutions+, Dunlee’s service portfolio, which supports customers in every step of product development, from system definition through operation 

For more information: www.dunlee.com 

Find more RSNA22 coverage here 


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
Feature | Computed Tomography (CT) | By Melinda Taschetta-Millane

In the ever-evolving landscape of medical imaging, computed tomography (CT) stands out as a cornerstone technology ...

Time July 30, 2024
arrow
Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
Feature | Radiology Business | By Christine Book

Across the healthcare industry, and, notably, throughout the radiology community in just the past few years, the focus ...

Time July 26, 2024
arrow
Feature | Mobile C-Arms | By Melinda Taschetta-Millane

Mobile C-arms continue to revolutionize medical imaging, offering versatility, mobility and real-time visualization ...

Time July 26, 2024
arrow
News | Radiology Business

July 25, 2024 — The radiology gender gap is decreasing, but there remains work to be done, according to an editorial ...

Time July 25, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
Subscribe Now